Cargando…

Gene mutation detection of urinary sediment cells for NMIBC early diagnose and prediction of NMIBC relapse after surgery

Early diagnose of bladder cancer could lead to good prognosis and high 5-year-survival rate. Among bladder cancer, about 75% patients with were nonmuscle-invasive bladder cancer (NMIBC). Patients were painful and easily get infected during bladder cancer diagnosis, which mainly depends on invasive c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Feng, Zhang, Yan, Shi, Lei, Wu, Chun-lei, Chen, Shuai-qi, Zheng, Hang, Song, Dong-kui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709296/ https://www.ncbi.nlm.nih.gov/pubmed/31393349 http://dx.doi.org/10.1097/MD.0000000000016451

Ejemplares similares

Intravesical ICIs to reduce toxicity in NMIBC
por: Masone, Maria Chiara
Publicado: (2022)

NBI cystoscopy and bipolar electrosurgery in NMIBC management – An overview of daily practice
por: Geavlete, B, et al.
Publicado: (2013)

Editorial: New frontiers in “bladder sparing” treatments for high risk NMIBC
por: Hurle, Rodolfo, et al.
Publicado: (2023)

The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M
por: Sun, Jian-Xuan, et al.
Publicado: (2023)

Comprehensive Gene Expression Analysis in NMIBC Using RNA-seq Reveals New Therapy Strategies
por: Chen, Xiaoliang, et al.
Publicado: (2019)

BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants
por: Suh, Jungyo, et al.
Publicado: (2019)

Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway
por: Zhang, Yuhang, et al.
Publicado: (2023)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study
por: Zhang, Heng, et al.
Publicado: (2020)

Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non‐muscle‐invasive bladder cancer (NMIBC)
por: Bilim, Vladimir, et al.
Publicado: (2022)

Preoperative Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Potential Recurrence Risk in NMIBC
por: Li, Shuaishuai, et al.
Publicado: (2022)

The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
por: Liu, Shenghua, et al.
Publicado: (2015)

Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study
por: Pirzada, Muhammad T, et al.
Publicado: (2017)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

Back-Splicing Transcript Isoforms (Circular RNAs) Affect Biologically Relevant Pathways and Offer an Additional Layer of Information to Stratify NMIBC Patients
por: Goel, Anshita, et al.
Publicado: (2020)

Immune responses against SARS-CoV-2 wildtype in unvaccinated patients with high-risk NMIBC undergoing intravesical BCG therapy
por: Pichler, R., et al.
Publicado: (2023)

Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer
por: Blazeby, Jane M., et al.
Publicado: (2014)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Nicklas, André P., et al.
Publicado: (2018)

Elicitation of Health State Utilities Associated with Progression from Bacillus Calmette-Guerin (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)
por: Cooper, Owen Alan Edwards, et al.
Publicado: (2023)

Interruption of BCG Therapy for NMIBC During COVID-19 Crisis, Dilemma in Its Continuation: a Review of Available Evidence and Suggested Management Strategies
por: Tosh, Jyoti Mohan, et al.
Publicado: (2023)

Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)
por: Broughton, Edward I., et al.
Publicado: (2022)

A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients – Design of the Urodiag® PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC)
por: Roperch, Jean-Pierre, et al.
Publicado: (2020)

Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)
por: Steinberg, Gary, et al.
Publicado: (2015)

Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies
por: Breyer, Johannes, et al.
Publicado: (2017)

The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC)
por: Rezaee, Michael E., et al.
Publicado: (2020)

Treatment Outcomes of High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) in Real-World Evidence (RWE) Studies: Systematic Literature Review (SLR)
por: Musat, Mihaela Georgiana, et al.
Publicado: (2022)

Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non–muscle‐invasive bladder cancer (NMIBC): A cohort analysis
por: Jobczyk, Mateusz, et al.
Publicado: (2020)

A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)
por: Steinberg, Gary D, et al.
Publicado: (2014)

Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24
por: Park, Jinsung, et al.
Publicado: (2018)

Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2022)

External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer
por: Kim, Jae Yeon, et al.
Publicado: (2022)

From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC)
por: Deininger, Susanne, et al.
Publicado: (2022)

Treatment efficacy and tolerability of intravesical Bacillus Calmette-Guerin (BCG) - RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)
por: Farah, Naim B, et al.
Publicado: (2014)

‘Real-life experience’: recurrence rate at 3 years with Hexvix(®) photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC—a prospective controlled study
por: Gallagher, Kevin M., et al.
Publicado: (2017)

Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
por: Busetto, Gian Maria, et al.
Publicado: (2023)

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS)
por: Witjes, J Alfred, et al.
Publicado: (2013)

Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations
por: Moon, Young Joon, et al.
Publicado: (2022)

Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis
por: Del Giudice, Francesco, et al.
Publicado: (2023)

Atlas of Urinary Sediments
Publicado: (1900)

Automated urinary sediment detection for Fabry disease using deep-learning algorithms
por: Uryu, Hidetaka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v0qug82odvp3mfjvtihh9812h6